Finlay Vaccine Institute of Cuba

Only 9.5% of people in low-income countries have received a single dose of the vaccine. Cuba has a comprehensive plan to support vaccine distribution in the global south to make sure none are left behind

From November 15 to 25, 35 Italian volunteers participated in a clinical trial on the Soberana vaccine in Havana, Cuba. Thanks to its public and high quality biotechnological research and health care system, the Caribbean island is the only low-income country worldwide to have made its own COVID-19 vaccines